Liva Healthcare UK Limited


2021-07-012022-06-302022-06-30false10717560Liva Healthcare UK Limited2023-03-27iso4217:GBPxbrli:pure107175602021-07-01107175602022-06-30107175602021-07-012022-06-30107175602020-07-01107175602021-06-30107175602020-07-012021-06-3010717560bus:SmallEntities2021-07-012022-06-3010717560bus:AuditExempt-NoAccountantsReport2021-07-012022-06-3010717560bus:FullAccounts2021-07-012022-06-3010717560bus:PrivateLimitedCompanyLtd2021-07-012022-06-3010717560core:WithinOneYear2022-06-3010717560core:AfterOneYear2022-06-3010717560core:WithinOneYear2021-06-3010717560core:AfterOneYear2021-06-3010717560core:ShareCapital2022-06-3010717560core:SharePremium2022-06-3010717560core:RevaluationReserve2022-06-3010717560core:OtherReservesSubtotal2022-06-3010717560core:RetainedEarningsAccumulatedLosses2022-06-3010717560core:ShareCapital2021-06-3010717560core:SharePremium2021-06-3010717560core:RevaluationReserve2021-06-3010717560core:OtherReservesSubtotal2021-06-3010717560core:RetainedEarningsAccumulatedLosses2021-06-3010717560core:LandBuildings2022-06-3010717560core:PlantMachinery2022-06-3010717560core:Vehicles2022-06-3010717560core:FurnitureFittings2022-06-3010717560core:OfficeEquipment2022-06-3010717560core:NetGoodwill2022-06-3010717560core:IntangibleAssetsOtherThanGoodwill2022-06-3010717560core:ListedExchangeTraded2022-06-3010717560core:UnlistedNon-exchangeTraded2022-06-3010717560core:LandBuildings2021-06-3010717560core:PlantMachinery2021-06-3010717560core:Vehicles2021-06-3010717560core:FurnitureFittings2021-06-3010717560core:OfficeEquipment2021-06-3010717560core:NetGoodwill2021-06-3010717560core:IntangibleAssetsOtherThanGoodwill2021-06-3010717560core:ListedExchangeTraded2021-06-3010717560core:UnlistedNon-exchangeTraded2021-06-3010717560core:LandBuildings2021-07-012022-06-3010717560core:PlantMachinery2021-07-012022-06-3010717560core:Vehicles2021-07-012022-06-3010717560core:FurnitureFittings2021-07-012022-06-3010717560core:OfficeEquipment2021-07-012022-06-3010717560core:NetGoodwill2021-07-012022-06-3010717560core:IntangibleAssetsOtherThanGoodwill2021-07-012022-06-3010717560core:ListedExchangeTraded2021-07-012022-06-3010717560core:UnlistedNon-exchangeTraded2021-07-012022-06-3010717560core:MoreThanFiveYears2021-07-012022-06-3010717560core:Non-currentFinancialInstruments2022-06-3010717560core:Non-currentFinancialInstruments2021-06-3010717560dpl:CostSales2021-07-012022-06-3010717560dpl:DistributionCosts2021-07-012022-06-3010717560dpl:AdministrativeExpenses2021-07-012022-06-3010717560core:LandBuildings2021-07-012022-06-3010717560core:PlantMachinery2021-07-012022-06-3010717560core:Vehicles2021-07-012022-06-3010717560core:FurnitureFittings2021-07-012022-06-3010717560core:OfficeEquipment2021-07-012022-06-3010717560core:NetGoodwill2021-07-012022-06-3010717560core:IntangibleAssetsOtherThanGoodwill2021-07-012022-06-3010717560dpl:GroupUndertakings2021-07-012022-06-3010717560dpl:ParticipatingInterests2021-07-012022-06-3010717560dpl:GroupUndertakingscore:ListedExchangeTraded2021-07-012022-06-3010717560core:ListedExchangeTraded2021-07-012022-06-3010717560dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-07-012022-06-3010717560core:UnlistedNon-exchangeTraded2021-07-012022-06-3010717560dpl:CostSales2020-07-012021-06-3010717560dpl:DistributionCosts2020-07-012021-06-3010717560dpl:AdministrativeExpenses2020-07-012021-06-3010717560core:LandBuildings2020-07-012021-06-3010717560core:PlantMachinery2020-07-012021-06-3010717560core:Vehicles2020-07-012021-06-3010717560core:FurnitureFittings2020-07-012021-06-3010717560core:OfficeEquipment2020-07-012021-06-3010717560core:NetGoodwill2020-07-012021-06-3010717560core:IntangibleAssetsOtherThanGoodwill2020-07-012021-06-3010717560dpl:GroupUndertakings2020-07-012021-06-3010717560dpl:ParticipatingInterests2020-07-012021-06-3010717560dpl:GroupUndertakingscore:ListedExchangeTraded2020-07-012021-06-3010717560core:ListedExchangeTraded2020-07-012021-06-3010717560dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2020-07-012021-06-3010717560core:UnlistedNon-exchangeTraded2020-07-012021-06-3010717560core:NetGoodwill2022-06-3010717560core:IntangibleAssetsOtherThanGoodwill2022-06-3010717560core:LandBuildings2022-06-3010717560core:PlantMachinery2022-06-3010717560core:Vehicles2022-06-3010717560core:FurnitureFittings2022-06-3010717560core:OfficeEquipment2022-06-3010717560core:AfterOneYear2022-06-3010717560core:WithinOneYear2022-06-3010717560core:ListedExchangeTraded2022-06-3010717560core:UnlistedNon-exchangeTraded2022-06-3010717560core:ShareCapital2022-06-3010717560core:SharePremium2022-06-3010717560core:RevaluationReserve2022-06-3010717560core:OtherReservesSubtotal2022-06-3010717560core:RetainedEarningsAccumulatedLosses2022-06-3010717560core:NetGoodwill2021-06-3010717560core:IntangibleAssetsOtherThanGoodwill2021-06-3010717560core:LandBuildings2021-06-3010717560core:PlantMachinery2021-06-3010717560core:Vehicles2021-06-3010717560core:FurnitureFittings2021-06-3010717560core:OfficeEquipment2021-06-3010717560core:AfterOneYear2021-06-3010717560core:WithinOneYear2021-06-3010717560core:ListedExchangeTraded2021-06-3010717560core:UnlistedNon-exchangeTraded2021-06-3010717560core:ShareCapital2021-06-3010717560core:SharePremium2021-06-3010717560core:RevaluationReserve2021-06-3010717560core:OtherReservesSubtotal2021-06-3010717560core:RetainedEarningsAccumulatedLosses2021-06-3010717560core:NetGoodwill2020-07-0110717560core:IntangibleAssetsOtherThanGoodwill2020-07-0110717560core:LandBuildings2020-07-0110717560core:PlantMachinery2020-07-0110717560core:Vehicles2020-07-0110717560core:FurnitureFittings2020-07-0110717560core:OfficeEquipment2020-07-0110717560core:AfterOneYear2020-07-0110717560core:WithinOneYear2020-07-0110717560core:ListedExchangeTraded2020-07-0110717560core:UnlistedNon-exchangeTraded2020-07-0110717560core:ShareCapital2020-07-0110717560core:SharePremium2020-07-0110717560core:RevaluationReserve2020-07-0110717560core:OtherReservesSubtotal2020-07-0110717560core:RetainedEarningsAccumulatedLosses2020-07-0110717560core:AfterOneYear2021-07-012022-06-3010717560core:WithinOneYear2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:CostValuation2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-07-012022-06-3010717560core:Non-currentFinancialInstrumentscore:CostValuation2022-06-3010717560core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-06-3010717560core:Non-currentFinancialInstrumentscore:CostValuation2021-06-3010717560core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-06-3010717560core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-06-3010717560core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-06-3010717560core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-06-3010717560core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-06-3010717560core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-06-3010717560core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-06-3010717560core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-06-3010717560bus:Director12021-07-012022-06-3010717560bus:Director22021-07-012022-06-30

Liva Healthcare UK Limited

Registered Number
10717560
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2022

Liva Healthcare UK Limited
Company Information
for the year from 1 July 2021 to 30 June 2022

Directors

BECH, R
SHARIF, Sharham

Registered Address

65 Woodbridge Road
Guildford
GU1 4RD

Registered Number

10717560 (England and Wales)
Liva Healthcare UK Limited
Statement of Financial Position
30 June 2022

Notes

2022

2021

£

£

£

£

Fixed assets
Tangible assets86,2827,668
6,2827,668
Current assets
Debtors11114,953182,398
Cash at bank and on hand108,69453,727
223,647236,125
Creditors amounts falling due within one year12(2,350,175)(1,553,484)
Net current assets (liabilities)(2,126,528)(1,317,359)
Total assets less current liabilities(2,120,246)(1,309,691)
Net assets(2,120,246)(1,309,691)
Capital and reserves
Called up share capital11
Profit and loss account(2,120,247)(1,309,692)
Shareholders' funds(2,120,246)(1,309,691)
  • The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.
The financial statements were approved and authorised for issue by the Board of Directors on 27 March 2023, and are signed on its behalf by:
BECH, R
Director
Registered Company No. 10717560
Liva Healthcare UK Limited
Notes to the Financial Statements
for the year ended 30 June 2022

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company in the year under review was that of a healthcare app for personal health coaching.
4.Basis of measurement used in financial statements
The financial statements have been prepared under the historical cost convention.
5.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Property, plant and equipment policy
Tangible assets are stated at cost (or deemed cost), less accumulated depreciation and accumulated impairment losses. Cost includes the original purchase price, costs directly attributable to bringing the asset to its working condition for its intended use, dismantling and restoration costs. Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Straight line (years)
Office Equipment3
Revenue recognition policy
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. The statement of financial position is credited with the value of invoiced sales, as deferred income, which is then amortised to revenue over the period of the contract. At the statement of financial position date, the carrying value of deferred income reflects the total value of invoiced sales which has not yet been recognised as revenue.
Taxation policy
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that that have been enacted or substantively enacted by the statement of financial position date.
Foreign currency translation and operations policy
Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each reporting period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at the period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the income statement.
Leases policy
Rentals paid under operating leases are charged to the income statement on a straight-line basis.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
Valuation of financial instruments policy
The Company has chosen to adopt the Sections 11 and 12 of FRS 102 in respect of financial instruments. The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non puttable ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out right short term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Financial assets and liabilities are offset and the net amount reported in the Statement of Financial Position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Cash and cash equivalents comprise cash on hand and demand deposits and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk to changes in value.
Going concern
The financial statements have been prepared on a going concern basis. The company has made losses during the year however the entity’s parent company is committed to continuing to provide financial support to fund Liva Healthcare UK Limited, so that it can meet its obligations if and when they fall due, whilst the company establishes its presence and business reach in the UK market. It is on this basis that the directors are of the opinion that they should continue to adopt the going concern basis of accounting in preparing the financial statements
6.Critical estimates and judgements
There are no significant judgements or estimates applied to the numbers contained within these financial statements.
7.Employee information

20222021
Average number of employees during the year166
8.Property, plant and equipment

Office Equipment

Total

££
Cost or valuation
At 01 July 2117,97417,974
Additions4,8754,875
At 30 June 2222,84922,849
Depreciation and impairment
At 01 July 2110,30610,306
Charge for year6,2616,261
At 30 June 2216,56716,567
Net book value
At 30 June 226,2826,282
At 30 June 217,6687,668
9.Description of financial commitments other than capital commitments
Future payments under non-cancellable operating lease agreements fall due as follows: Within 1 year = £18,675 (2021: £Nil)
10.Description of nature of transactions and balances with related parties
The company has taken advantage of the exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with other companies within the group. Ultimate Controlling party. Liva Healthcare A/S is the ultimate controlling entity situated at Danneskiold-Samsoes, Alle 41, Copenhagen K, Dk-1434, Denmark.
11.Debtors

2022

2021

££
Trade debtors / trade receivables94,674118,011
Other debtors8,0909,970
Prepayments and accrued income12,18954,417
Total114,953182,398
12.Creditors within one year

2022

2021

££
Trade creditors / trade payables4,0608,463
Amounts owed to related parties2,187,9381,442,593
Taxation and social security52,72925,576
Other creditors11,8956,516
Accrued liabilities and deferred income93,55370,336
Total2,350,1751,553,484